Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits(The Netherlands Cancer Institute), Jacques Neefjes(Leiden University Medical Center), Peter A. van Veelen(Leiden University Medical Center), Elly Mesman(The Netherlands Cancer Institute), Rosalie M. Luiten(Amsterdam Institute for Addiction Research), Arnold H. de Ru(Leiden University Medical Center), Kevin Camphausen(National Cancer Institute), Joost Neijssen(The Netherlands Cancer Institute), Carla Herberts(Medicines Evaluation Board), Elizabeth K. Wansley, Jeffrey Schlom(National Cancer Institute), Alexander Griekspoor(The Netherlands Cancer Institute), Frank A. W. Verreck(Biomedical Primate Research Centre), Hergen Spits(Erasmus MC Cancer Institute), James W. Hodge(National Cancer Institute), Mala Chakraborty, Tom A. Groothuis(The Netherlands Cancer Institute)
Cited by 1,702
Related Papers
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|973
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
|Blood|2005|896
Risk factors in the development of stem cell therapy
|Journal of Translational Medicine|2011|760